Since CNDP1 is largely expressed by oligodendrocytes in the human CNS, the reduction we observe in RR patients could be due to pathological destruction of the myelin and oligodendrocytes in multiple sclerosis [21]. The gene discussed is CNDP1; the disease is multiple sclerosis.